AVR 2.97% $12.15 anteris technologies ltd

Interview on the Market Herald with Wayne., page-61

  1. 27,394 Posts.
    lightbulb Created with Sketch. 1781
    Investors think AVR have now secure funding for 1.5-2 years, it's all about the clinical trial result of TAVR which is used for younger patient so durability is very important....this is a massive market and the MC is currently only $33M, DYOR.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.